The purpose of the International Foundation for Anticancer Drug Discovery ("IFADD"), an Arizona non-profit corporation, tax-exempt 501(c)(3) and 501(h) charitable organization under the Internal Revenue Code, is to promote greater public awareness of promising anticancer drug discovery efforts which might well become part of tomorrow's standard anticancer armamentarium. IFADD seeks to enhance and accelerate the anticancer drug pipeline through aggressive cancer patient advocacy, public education, and legislation at both federal and state levels.

IFADD has dealt with thousands of cancer patients and inquiries from members of the public since its inception, providing an aggressively unique and cutting-edge approach to every case as no two cancer patients are alike. Cancer is a complex disease that is both antithetical to and defies a formulaic approach. Patients have differing experiences with the same drug regimen, react to a drug's side effects differently, and experience multi-drug resistance at different times. In the over over 125 types of cancers we have had experience with, IFADD has never seen a cancer diagnosis or a cancer patient like any other. What separates IFADD from the rest of the panoply of cancer organizations is the detailed and strategically creative assistance provided to each cancer patient because of the organization's resources and fluency in the anticancer drug pipeline. We work very closely with the patient or his/her family to provide the patient's medical and support teams with options that they may not have previously considered.